Your browser doesn't support javascript.
loading
An HLA-modified ovarian cancer cell line induced CTL responses specific to an epitope derived from claudin-1 presented by HLA-A*24:02 molecules.
Kondo, Shinji; Demachi-Okamura, Ayako; Hirosawa, Tomoya; Maki, Hiroyuki; Fujita, Mitsugu; Uemura, Yasushi; Akatsuka, Yoshiki; Yamamoto, Eiko; Shibata, Kiyosumi; Ino, Kazuhiko; Kikkawa, Fumitaka; Kuzushima, Kiyotaka.
Affiliation
  • Kondo S; Division of Immunology, Aichi Cancer Center Research Institute, Nagoya 464-8681, Japan.
Hum Immunol ; 74(9): 1103-10, 2013 Sep.
Article in En | MEDLINE | ID: mdl-23806269
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Peptide Fragments / T-Lymphocytes, Cytotoxic / Adenocarcinoma, Clear Cell / Epitopes, T-Lymphocyte / HLA-A24 Antigen / Claudin-1 Limits: Adult / Female / Humans Language: En Journal: Hum Immunol Year: 2013 Document type: Article Affiliation country: Japan Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Peptide Fragments / T-Lymphocytes, Cytotoxic / Adenocarcinoma, Clear Cell / Epitopes, T-Lymphocyte / HLA-A24 Antigen / Claudin-1 Limits: Adult / Female / Humans Language: En Journal: Hum Immunol Year: 2013 Document type: Article Affiliation country: Japan Country of publication: United States